[LGND] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
28-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -136.20%
YoY- -186.24%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 66,088 57,419 45,693 72,473 64,835 84,675 55,150 12.80%
PBT 857 -636 -20,140 -7,026 15,259 33,301 5,764 -71.90%
Tax 453 259 -4,755 -2,058 1,536 2,576 -12,342 -
NP 404 -895 -15,385 -4,968 13,723 30,725 18,106 -92.05%
Tax Rate -52.86% - - - -10.07% -7.74% 214.12% -
Total Cost 65,684 58,314 61,078 77,441 51,112 53,950 37,044 46.44%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 0.61 -1.56 -33.67 -6.85 21.17 36.29 32.83 -92.96%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS 0.02 -0.05 -0.92 -0.30 0.82 1.84 1.10 -93.06%
EPS Diluted 0.02 -0.05 -0.91 -0.30 0.80 1.79 1.05 -92.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.